Home › Companies › AGILON HEALTH INC. › 2023-2024

AGILON HEALTH INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and AGILON HEALTH INC.’s Form 8-K, filed 2024-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 189Asset managers
  • 1,467Fund votes
  • 2024-05-29Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AGILON HEALTH INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by AGILON HEALTH INC.

These tallies are AGILON HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AGILON HEALTH INC. — official shareholder meeting results, meeting held 2024-05-29
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Ravi Sachdev 359,574,46625,246,100106,890 --7,698,907 Majority: yes
Elect Director: Steven J. Sell 362,777,06322,042,462107,931 --7,698,907 Majority: yes
Elect Director: William Wulf, M.D. 359,928,89424,926,63371,929 --7,698,907 Majority: yes
Proposal 2: Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. 391,453,8081,087,70284,853 ---- Majority: yes
Proposal 3: Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers. 318,678,23666,152,44496,776 --7,698,907 Majority: yes

Source: AGILON HEALTH INC., Form 8-K, filed with the SEC on 2024-06-03 — read the filing on EDGAR.

How asset managers voted at the AGILON HEALTH INC. 2023-2024 meeting

Each item below shows how the 189 asset managers that disclosed a AGILON HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, by advisory vote, the compensation paid to the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 318,678,236AGAINST: 66,152,444

AGILON HEALTH INC.’s own tally for this item (“Proposal 3: Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”): 318,678,236 for, 66,152,444 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 410,843,000 outstanding shares: 78% for, 16% against (94% of the company cast a for/against vote).

The 187 asset managers below cast 72% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 72%AGAINST 28%
FOR: 72.4%AGAINST: 27.5%ABSTAIN: 0.0%
Largest asset managers voting on “To approve, by advisory vote, the compensation paid to the Company's named executive officers.” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group1,068108,832,843 00Against
Fidelity81,041,8930 00For
Morgan Stanley67,432,6170 00For
Vanguard63,828,9810 00For
Wellington52,076,5580 00For
NEW ECONOMY FUND09,195,960 00Against
BlackRock7,894,6590 00For
Rock Springs Capital Management LP7,347,7920 00For
Hartford6,920,9290 00For
Charles Schwab4,335,8150 00For
Brighthouse3,182,7600 00For
AMCAP FUND02,895,418 00Against
State Street2,843,6200 00For
GEODE CAPITAL MANAGEMENT, LLC2,746,9520 00For
Bridgewater2,642,6900 00For
T. Rowe Price2,572,0230 00For
BROWN ADVISORY INC2,050,1700 00For
Daventry Group, LP1,750,2490 00For
Transamerica1,587,8890 00For
DWS1,017,5790 00For
Northern Trust1,012,1810 00For
Durable Capital Partners LP976,1330 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds815,1610 00For
Man Group plc750,2200 00For

Showing the 25 largest of 187 asset managers. See all 187 in the interactive database.

2. Election of Class III Directors: Ravi Sachdev

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 359,574,466AGAINST: 25,246,100

AGILON HEALTH INC.’s own tally for this item (“Elect Director: Ravi Sachdev”): 359,574,466 for, 25,246,100 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 410,843,000 outstanding shares: 88% for, 6% against (94% of the company cast a for/against vote).

The 59 asset managers below cast 98% of the shares they voted on this item FOR (203,220,010 for, 3,156,774 against).

FOR 98%
FOR: 203,220,010 (98.5%)AGAINST: 3,156,774 (1.5%)
Largest asset managers voting on “Election of Class III Directors: Ravi Sachdev” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,711,8554,493 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,178,1794,581 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS01,016,618 00Against
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds0815,161 00Against
Equitable649,59770,523 00For
Principal0317,160 00Against
John Hancock226,6267,015 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs0175,435 00Against
AGF Investments Trust0165,508 00Against
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert0144,974 00Against
Guardian Variable Products Trust129,6070 00For
TIAA0125,247 00Against

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

3. Election of Class III Directors: Steven J. Sell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 362,777,063AGAINST: 22,042,462

AGILON HEALTH INC.’s own tally for this item (“Elect Director: Steven J. Sell”): 362,777,063 for, 22,042,462 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 410,843,000 outstanding shares: 88% for, 5% against (94% of the company cast a for/against vote).

The 59 asset managers below cast 99% of the shares they voted on this item FOR (203,584,811 for, 2,791,973 against).

FOR 99%
FOR: 203,584,811 (98.6%)AGAINST: 2,791,973 (1.4%)
Largest asset managers voting on “Election of Class III Directors: Steven J. Sell” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,711,8554,493 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,178,1794,581 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS01,016,618 00Against
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds0815,161 00Against
Equitable720,1200 00For
Principal0317,160 00Against
John Hancock226,6267,015 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs0175,435 00Against
AGF Investments Trust0165,508 00Against
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert0144,974 00Against
Guardian Variable Products Trust129,6070 00For
TIAA125,2470 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. Election of Class III Directors: William Wulf, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 359,928,894AGAINST: 24,926,633

AGILON HEALTH INC.’s own tally for this item (“Elect Director: William Wulf, M.D.”): 359,928,894 for, 24,926,633 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 410,843,000 outstanding shares: 88% for, 6% against (94% of the company cast a for/against vote).

The 59 asset managers below cast 99% of the shares they voted on this item FOR (203,337,806 for, 3,038,978 against).

FOR 99%
FOR: 203,337,806 (98.5%)AGAINST: 3,038,978 (1.5%)
Largest asset managers voting on “Election of Class III Directors: William Wulf, M.D.” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,711,8554,493 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,178,1794,581 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS01,016,618 00Against
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds0815,161 00Against
Equitable649,59770,523 00For
Principal0317,160 00Against
John Hancock226,6267,015 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs0175,435 00Against
AGF Investments Trust0165,508 00Against
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert0144,974 00Against
Guardian Variable Products Trust129,6070 00For
TIAA0125,247 00Against

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

5. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 391,453,808AGAINST: 1,087,702

AGILON HEALTH INC.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ”): 391,453,808 for, 1,087,702 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 410,843,000 outstanding shares: 95% for, 0.3% against (96% of the company cast a for/against vote).

The 59 asset managers below cast 100% of the shares they voted on this item FOR (206,376,784 for, 0 against).

FOR 100%
FOR: 206,376,784 (100.0%)
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,716,3480 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,182,7600 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS1,016,6180 00For
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds815,1610 00For
Equitable720,1200 00For
Principal317,1600 00For
John Hancock233,6410 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs175,4350 00For
AGF Investments Trust165,5080 00For
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert144,9740 00For
Guardian Variable Products Trust129,6070 00For
TIAA125,2470 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

Largest AGILON HEALTH INC. shareholders voting in 2023-2024

Ranked by the number of AGILON HEALTH INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 410,843,000 shares outstanding at the time of that meeting.

Top AGILON HEALTH INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Capital Group 26.49%
2Fidelity 19.73%
3Morgan Stanley 16.41%
4Vanguard 15.54%
5Wellington 12.68%
6NEW ECONOMY FUND 2.24%
7BlackRock 1.92%
8Rock Springs Capital Management LP 1.79%
9Hartford 1.68%
10Charles Schwab 1.06%

Reported AGILON HEALTH INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

AGILON HEALTH INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
CD&R Vector Holdings, L.P. 24.34% DEF14A
FMR LLC 14.79% DEF14A
Wellington Management 13.83% 13F
Capital World Investors 13.44% DEF14A
Morgan Stanley 10.66% DEF14A
Vanguard Group 5.91% 13F
BlackRock 5.89% 13F
FMR (Fidelity) 3.81% 13F
Goldman Sachs 1.65% 13F
State Street 1.26% 13F

Percentages above are of 410,843,000 shares outstanding, as reported by AGILON HEALTH INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AGILON HEALTH INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At AGILON HEALTH INC.'s shareholder meeting held 2024-05-29, in the 2023-2024 proxy season, 189 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,467 separate fund positions. On the most widely held item on that ballot — To approve, by advisory vote, the compensation paid to the Company's named executive officers. — FOR was 83% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AGILON HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-03.

AGILON HEALTH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.